GlassScriptPhysician profile
Vincent Cubelli
NPI 1053353474
$3,773.62
in general payments reported to CMS, 2019-2025
45 companies · $653 in 2025
The $653 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $79.23 · 2021: $351 · 2022: $846 · 2023: $927 · 2024: $724 · 2025: $653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,303.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $334.05 | 2023-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $315.09 | 2021-2023 | Aquabeam Robotic System |
| Abbvie INC. | $296.16 | 2023-2025 | Botox |
| Janssen Biotech, INC. | $292.15 | 2019-2025 | Erleada |
| Myriad Genetic Laboratories, INC. | $235.62 | 2022-2025 | Prolaris |
| Astellas Pharma US INC | $231.68 | 2019-2023 | Myrbetriq |
| 180 Medical, INC. | $183.06 | 2019-2025 | |
| Telix Pharmaceuticals | $178.91 | 2023-2025 | Illuccix |
| Astrazeneca Pharmaceuticals LP | $164.52 | 2022-2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $141.90 | 2023-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $139.69 | 2019-2025 | |
| Urogen Pharma, INC. | $130.42 | 2023-2025 | Jelmyto |
| Pfizer INC. | $112.61 | 2020-2023 | |
| Urovant Sciences INC | $100.29 | 2021-2022 | |
| Tolmar, INC. | $83.09 | 2023-2025 | Eligard, Jatenzo |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $72.26 | 2022-2025 | Itind System |
| Boston Scientific Corporation | $71.88 | 2022-2024 | Ams 700 |
| Merck Sharp & Dohme LLC | $56.24 | 2023-2025 | Keytruda, Keytruda Qlex, Lynparza |
| Myovant Sciences INC. | $54.88 | 2022 | |
| Antares Pharma, INC. | $50.79 | 2022-2025 | Xyosted |
| Ferring Pharmaceuticals INC. | $44.85 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $39.96 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $29.37 | 2019-2020 | |
| Clarus Therapeutics INC. | $28.73 | 2021 | |
| Bioprotect Medical, INC. | $27.86 | 2025 | Bioprotect Balloon Implant System |
| Hollister Incorporated | $27.83 | 2020-2022 | |
| Zyla Life Sciences, INC. | $25.96 | 2019 | |
| Agiliti Surgical, INC. | $25.51 | 2023 | Sonablate |
| Palette Life Sciences, INC. | $24.08 | 2022 | |
| Sun Pharmaceutical Industries INC. | $23.14 | 2024 | |
| Teleflex LLC | $18.97 | 2021 | |
| Cook Medical LLC | $18.77 | 2024 | Cook |
| Immunitybio, INC. | $16.71 | 2025 | |
| Laborie Medical Technologies Corp. | $16.55 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $16.48 | 2024 | Aveed, Xiaflex |
| Calyxo, INC. | $15.72 | 2024 | Cvac Aspiration System |
| Endo Pharmaceuticals INC. | $14.93 | 2023 | Aveed, Xiaflex |
| Tolmar Pharmaceuticals, INC. | $14.92 | 2021 | |
| Dentsply Ih Ab | $14.88 | 2021 | |
| Medtronic, INC. | $14.82 | 2021 | |
| Coloplast Corp | $14.71 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.96 | 2025 | |
| Profound Medical Corp. | $13.62 | 2025 | Tulsa-Pro |
| Allergan, INC. | $13.19 | 2019 | |
| Aytu Biopharma, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Cubelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.